Cargando…
Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer
Homologous recombination DNA-repair deficiency (HRD) is a common driver of genomic instability and confers a therapeutic vulnerability in cancer. The accurate detection of somatic allelic imbalances (AIs) has been limited by methods focused on BRCA1/2 mutations and using mixtures of cancer types. Us...
Autores principales: | Perez-Villatoro, Fernando, Oikkonen, Jaana, Casado, Julia, Chernenko, Anastasiya, Gulhan, Doga C., Tumiati, Manuela, Li, Yilin, Lavikka, Kari, Hietanen, Sakari, Hynninen, Johanna, Haltia, Ulla-Maija, Tyrmi, Jaakko S., Laivuori, Hannele, Konstantinopoulos, Panagiotis A., Hautaniemi, Sampsa, Kauppi, Liisa, Färkkilä, Anniina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800569/ https://www.ncbi.nlm.nih.gov/pubmed/36581696 http://dx.doi.org/10.1038/s41698-022-00339-8 |
Ejemplares similares
-
Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
por: Pikkusaari, Sanna, et al.
Publicado: (2023) -
Prospective Longitudinal ctDNA Workflow Reveals Clinically Actionable Alterations in Ovarian Cancer
por: Oikkonen, Jaana, et al.
Publicado: (2019) -
Author Correction: Virtual clinical trials identify effective combination therapies in ovarian cancer
por: Kozłowska, Emilia, et al.
Publicado: (2020) -
Virtual clinical trials identify effective combination therapies in ovarian cancer
por: Kozłowska, Emilia, et al.
Publicado: (2019) -
Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrence
por: Marchi, Giovanni, et al.
Publicado: (2023)